| Profile | GDS5420 / 204154_at |
| Title | Psoriasis response to brodalumab: dose response and time course |
| Organism | Homo sapiens |
| Sample | Title | Value | Rank |
|---|---|---|---|
| GSM1296094 | A_lesional_pre-dose | 82.78 | 39 |
| GSM1296119 | B_lesional_pre-dose | 261.86 | 57 |
| GSM1296076 | C_lesional_pre-dose | 142.21 | 48 |
| GSM1296092 | D_lesional_pre-dose | 135.73 | 48 |
| GSM1296103 | E_lesional_pre-dose | 49.64 | 31 |
| GSM1296078 | F_lesional_pre-dose | 523.02 | 70 |
| GSM1296107 | G_lesional_pre-dose | 1459.31 | 85 |
| GSM1296109 | H_lesional_pre-dose | 264.54 | 56 |
| GSM1296080 | I_lesional_pre-dose | 183.8 | 52 |
| GSM1296090 | J_lesional_pre-dose | 324.74 | 61 |
| GSM1296074 | K_lesional_pre-dose | 139.56 | 49 |
| GSM1296111 | L_lesional_pre-dose | 355.88 | 62 |
| GSM1296099 | M_lesional_pre-dose | 117.8 | 44 |
| GSM1296086 | O_lesional_pre-dose | 183.76 | 52 |
| GSM1296117 | P_lesional_pre-dose | 243.06 | 55 |
| GSM1296113 | Q_lesional_pre-dose | 326.21 | 60 |
| GSM1296096 | R_lesional_pre-dose | 189.56 | 52 |
| GSM1296105 | S_lesional_pre-dose | 1036.9 | 80 |
| GSM1296098 | T_lesional_pre-dose | 79.55 | 37 |
| GSM1296101 | U_lesional_pre-dose | 115.09 | 43 |
| GSM1296121 | V_lesional_pre-dose | 332.33 | 61 |
| GSM1296088 | W_lesional_pre-dose | 219.56 | 54 |
| GSM1296082 | X_lesional_pre-dose | 85.19 | 41 |
| GSM1296115 | Y_lesional_pre-dose | 275.3 | 57 |
| GSM1296084 | Z_lesional_pre-dose | 156.83 | 49 |
| GSM1296072 | B_lesional_day8 | 259.08 | 56 |
| GSM1296069 | L_lesional_day8 | 682.95 | 73 |
| GSM1296071 | P_lesional_day8 | 670.64 | 72 |
| GSM1296070 | Y_lesional_day8 | 481.62 | 67 |
| GSM1296073 | V_lesional_day8 | 399.92 | 64 |
| GSM1296034 | A_lesional_day15 | 116.43 | 43 |
| GSM1296041 | G_lesional_day15 | 611.04 | 71 |
| GSM1296035 | R_lesional_day15 | 179.63 | 51 |
| GSM1296038 | U_lesional_day15 | 360.34 | 62 |
| GSM1296047 | B_lesional_day15 | 262.11 | 56 |
| GSM1296039 | E_lesional_day15 | 97.01 | 41 |
| GSM1296042 | H_lesional_day15 | 487.57 | 67 |
| GSM1296043 | L_lesional_day15 | 540.63 | 69 |
| GSM1296037 | M_lesional_day15 | 331.97 | 60 |
| GSM1296046 | P_lesional_day15 | 466.78 | 66 |
| GSM1296044 | Q_lesional_day15 | 966.09 | 79 |
| GSM1296045 | Y_lesional_day15 | 771.77 | 75 |
| GSM1296025 | C_lesional_day15 | 955.3 | 78 |
| GSM1296033 | D_lesional_day15 | 254.16 | 56 |
| GSM1296027 | I_lesional_day15 | 850.35 | 76 |
| GSM1296032 | J_lesional_day15 | 1360.07 | 84 |
| GSM1296024 | K_lesional_day15 | 812.6 | 76 |
| GSM1296031 | W_lesional_day15 | 1221.01 | 82 |
| GSM1296028 | X_lesional_day15 | 295.02 | 59 |
| GSM1296029 | Z_lesional_day15 | 409.78 | 64 |
| GSM1296026 | F_lesional_day15 | 575.73 | 70 |
| GSM1296030 | O_lesional_day15 | 225.08 | 56 |
| GSM1296040 | S_lesional_day15 | 558.33 | 69 |
| GSM1296036 | T_lesional_day15 | 75.14 | 36 |
| GSM1296048 | V_lesional_day15 | 575.96 | 70 |
| GSM1296059 | A_lesional_day43 | 163.09 | 50 |
| GSM1296066 | G_lesional_day43 | 726.85 | 74 |
| GSM1296060 | R_lesional_day43 | 291.84 | 58 |
| GSM1296063 | U_lesional_day43 | 831.56 | 76 |
| GSM1296064 | E_lesional_day43 | 224.62 | 55 |
| GSM1296067 | H_lesional_day43 | 628.42 | 71 |
| GSM1296062 | M_lesional_day43 | 154.11 | 48 |
| GSM1296068 | Q_lesional_day43 | 2681.71 | 94 |
| GSM1296050 | C_lesional_day43 | 2364.62 | 91 |
| GSM1296057 | D_lesional_day43 | 509.17 | 68 |
| GSM1296052 | I_lesional_day43 | 1037.94 | 79 |
| GSM1296054 | J_lesional_day43 | 273.27 | 57 |
| GSM1296049 | K_lesional_day43 | 704.12 | 73 |
| GSM1296055 | W_lesional_day43 | 703.57 | 73 |
| GSM1296053 | X_lesional_day43 | 257.82 | 56 |
| GSM1296058 | Z_lesional_day43 | 195.91 | 52 |
| GSM1296051 | F_lesional_day43 | 407.95 | 65 |
| GSM1296056 | O_lesional_day43 | 207.63 | 54 |
| GSM1296065 | S_lesional_day43 | 2252.36 | 91 |
| GSM1296061 | T_lesional_day43 | 328.78 | 60 |
| GSM1296095 | A_non-lesional_pre-dose | 394.4 | 64 |
| GSM1296120 | B_non-lesional_pre-dose | 211.12 | 52 |
| GSM1296077 | C_non-lesional_pre-dose | 1400.26 | 84 |
| GSM1296093 | D_non-lesional_pre-dose | 541.15 | 68 |
| GSM1296104 | E_non-lesional_pre-dose | 130.23 | 45 |
| GSM1296079 | F_non-lesional_pre-dose | 658.58 | 72 |
| GSM1296108 | G_non-lesional_pre-dose | 2366.45 | 91 |
| GSM1296110 | H_non-lesional_pre-dose | 419.16 | 64 |
| GSM1296081 | I_non-lesional_pre-dose | 3109.53 | 94 |
| GSM1296091 | J_non-lesional_pre-dose | 127.12 | 46 |
| GSM1296075 | K_non-lesional_pre-dose | 1053.68 | 80 |
| GSM1296112 | L_non-lesional_pre-dose | 1089.33 | 81 |
| GSM1296100 | M_non-lesional_pre-dose | 208.07 | 52 |
| GSM1296087 | O_non-lesional_pre-dose | 603.28 | 71 |
| GSM1296118 | P_non-lesional_pre-dose | 496.43 | 67 |
| GSM1296114 | Q_non-lesional_pre-dose | 397.79 | 63 |
| GSM1296097 | R_non-lesional_pre-dose | 398.68 | 64 |
| GSM1296106 | S_non-lesional_pre-dose | 701.74 | 73 |
| GSM1296102 | U_non-lesional_pre-dose | 379.92 | 62 |
| GSM1296122 | V_non-lesional_pre-dose | 1075.35 | 81 |
| GSM1296089 | W_non-lesional_pre-dose | 477.11 | 66 |
| GSM1296083 | X_non-lesional_pre-dose | 3083.15 | 94 |
| GSM1296116 | Y_non-lesional_pre-dose | 513.15 | 68 |
| GSM1296085 | Z_non-lesional_pre-dose | 353.37 | 62 |